Advanced Search

 

Study ID Status Title Patient Level Data
AC2108380 Completed A single-centre, randomized, double-blind placebo-controlled, dose-ascending, cross-over study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK233705, formulated with the excipient magnesium stearate, in healthy volunteers Study Listed on ClinicalStudyDataRequest.com
AC2110664 Completed Dose-Ranging Study for GSK233705B Delivered Once Daily in Subjects with COPD Study Listed on ClinicalStudyDataRequest.com
AC4106889 Completed A single-centre, randomised, double-blind, placebo-controlled, dose-ascending, 3-cohort parallel-group study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of GSK573719 administered as singledoses (750 μg and 1000 μg) and repeat doses over 14 days (250 μg–1000 μg once-daily) of GSK573719 in healthy male and female subjects. Study Listed on ClinicalStudyDataRequest.com
AC4108123 Completed A randomised, double blind, placebo-controlled, double dummy, 4-way cross-over, dose ascending study to assess the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK573719 (250, 500 and 1000 μg) and tiotropium bromide (18 μg) via DPI in COPD patients. Study Listed on ClinicalStudyDataRequest.com
AC5108696 Completed A randomized double-blind, placebo-controlled, crossover, dose escalation study to examine the safety, tolerability, pharmacodynamics and pharmacokinetics of single inhaled doses of GSK1160724 and tiotropium bromide
ACE104325 Completed A randomized, open label comparative study to determine the proportion of asthma patients on SERETIDE Diskus 50/250 mcg b.i.d. achieving Total Control when given medication and compliance enhancement training compared to those receiving medication only.
ACT1840 Completed A multicentre pilot study of natural pentasaccharide (SR90107A /Org31540) for the prevention of deep venous thrombosis after total hip replacement.
ACT2445 Completed Pilot efficacy study of a single I.V. injection of Pentasaccharide (SR90107A/ORG 31540) in patients undergoing coronary angioplasty
ACT2545 Completed A multicentre dose finding study of once daily injection of Natural Pentasaccharide for the prevention of deep vein thrombosis after total hip replacement.
ADA103575 Completed A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg QD versus Montelukast 10mg QD in Adolescent and Adult Subjects with Asthma and Seasonal Allergic Rhinitis Who are Receiving ADVAIR DISKUS® 100/50mcg BID or Placebo BID Study Listed on ClinicalStudyDataRequest.com
ADA103578 Completed A Multicenter, Randomized, Double-Blind, Triple-Dummy, Placebo-Controlled, Parallel Group, Four-Week Study Assessing the Efficacy of Fluticasone Propionate Aqueous Nasal Spray 200mcg QD versus Montelukast 10mg QD in Adolescent and Adult Subjects with Asthma and Seasonal Allergic Rhinitis Who are Receiving ADVAIR DISKUS® 100/50mcg BID or Placebo BID Study Listed on ClinicalStudyDataRequest.com
ADA109055 Completed A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Treatment of Subjects with Asthma Study Listed on ClinicalStudyDataRequest.com
ADA109057 Completed A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Treatment of Subjects with Asthma Study Listed on ClinicalStudyDataRequest.com
ADC105931 Terminated A Randomized, Double-Blind, Parallel-Group, 12-Week Study to Evaluate the Anti-Inflammatory Effect of Fluticasone Propionate/Salmeterol DISKUS 250/50mcg BID Compared with Salmeterol DISKUS 50mcg Twice Daily in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
ADC109043 Completed An evaluation of the prevalence of airway obstruction consistent with chronic obstructive pulmonary disease (COPD) in subjects with a history of cigarette smoking and symptoms of chronic bronchitis in a primary care setting
ADERE ADULT Completed A randomized, parallel group, open study to evaluate the impact of additional guidance provided by health care professionals on treatment compliance among asthmatic patients with persistent asthma (ADERE)
ADERE PEDIATRIC 1 Completed Prospective, parallel-group, randomized, open label study to evaluate the impact of additional guidance from the health professionals team on treatment compliance of children aged between 6 and 14 years old with persistent moderate or severe asthma, receiving the combination salmeterol/fluticaso ...
ADF104070 Completed An open label study of adefovir dipivoxil for the treatment of patients with chronic hepatitis B related advanced fibrosis or cirrhosis.
ADF105220 Completed Phase III study of Adefovir Dipivoxil tablets in patients with compensated chronic hepatitis B -Comparative study against Lamivudine-
ADF106632 Completed A 2-year multi-centre, open-label, local phase IV study to demonstrate the efficacy and safety of adefovir dipivoxil tablets (10mg) in Chinese subjects with HBe antigen negative Chronic Hepatitis B
ADF108005 Completed A phase IV, open label, single arm, multicenter, extension study of adefovir dipivoxil for Korean patients with chronic hepatitis B(CHB) who have completed ADF 103814
ADF108356 Completed A 48-week multi-centre, open-label, local phase IV study to demonstrate the efficacy and safety of adefovir dipivoxil tablets (10mg) in Chinese subjects with compensated Chronic Hepatitis B
ADF20001 Completed Open label compassionate access programme to provide adefovir dipivoxil to patients with chronic hepatitis B infection.
ADF30001 Completed A Multi-Centre, Double-Blind , Randomized, Placebo-Controlled Phase II/III Study of Adefovir Dipivoxil for the Treatment of Chinese Patients with HBeAg positive Chronic Hepatitis B Followed by Long-term (5 Years total) Adefovir Dipivoxil Treatment. (Report on Year 1 and Year 2 Data)
ADF30001 (Year 1 to Year 4) Completed A Multi-Center, Double-Blind , Randomized, Placebo-Controlled Phase II/III Study of Adefovir Dipivoxil for the Treatment of ChinesePatients with HBeAg positive Chronic Hepatitis B Followed by Long-term (5 Years total) Adefovir Dipivoxil Treatment. (Report on data outto 4 years)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.